Sma News & Perspectives

Early Trial Data Shows SRK-015 Increases Myostatin Growth Factor Levels in SMA Patients

Informações:

Sinopsis

We discuss early trial data that shows SRK-015 increases myostatin growth factor levels up to 100-fold in SMA patients & Forums Director Kevin Schaefer reads an excerpt from Alyssa Silva’s latest column. Are you interested in learning more about the spinal muscular atrophy? Please visit www.smanewstoday.com